tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Technical Analysis

Compare
154 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Dermata Therapeutics’s (DRMA) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Dermata Therapeutics is a Sell.
Dermata Therapeutics’s (DRMA) 20-Day exponential moving average is 1.36, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Buy.
Dermata Therapeutics’s (DRMA) 50-Day exponential moving average is 1.66, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.

Dermata Therapeutics (DRMA) Pivot Points

Mar 27, 2026, 01:59 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.07
1.19
1.38
1.50
1.69
1.81
2.00
Fibonacci
1.19
1.31
1.38
1.50
1.62
1.69
1.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Dermata Therapeutics (DRMA) Moving Averages

Mar 27, 2026, 01:59 AM
Period
Simple
Exponential
MA5
1.40Buy
1.44Buy
MA10
1.31Buy
1.37Buy
MA20
1.27Buy
1.36Buy
MA50
1.66Sell
1.66Sell
MA100
2.18Sell
2.37Sell
MA200
4.02Sell
4.07Sell
Dermata Therapeutics’s (DRMA) 10-Day exponential moving average is 1.37, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Buy.
Dermata Therapeutics’s (DRMA) 100-Day exponential moving average is 2.37, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 50-day simple moving average is 1.66, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 100-day simple moving average is 2.18, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 200-day simple moving average is 4.02, creating a Sell signal.

Dermata Therapeutics (DRMA) Technical Indicators

Mar 27, 2026, 01:59 AM
Name
Value
Implied Action
RSI (14)
55.91
Neutral
STOCH (9,6)
53.58
Neutral
STOCHRSI (14)
55.76
Neutral
MACD (12,26)
-0.05
Sell
ADX (14)
25.28
Neutral
Williams %R
-42.65
Buy
CCI (14)
193.05
Sell
ATR (14)
0.19
-
Ultimate Oscillator
52.74
Neutral
ROC
31.36
Buy
Dermata Therapeutics’s (DRMA) Relative Strength Index (RSI) is 55.91, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Trend Strength Indicator (ADX) is 25.28, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Commodity Channel Index (CCI) is 193.05, creating a Sell signal.
Dermata Therapeutics’s (DRMA) Price Rate of Change (ROC) is 31.36, creating a Buy signal.

FAQ

Is DRMA a Buy, Hold, or Sell?
Based on DRMA’s technical indicators, DRMA is a Hold.
    What is DRMA’s RSI (14)?
    DRMA’s RSI (14) is 55.91, which suggests DRMA is a Neutral.
      What is DRMA’s MACD?
      DRMA’s MACD is -0.05, which suggests DRMA is a Sell.
        What is DRMA’s 5-day moving average?
        DRMA’s 5-day moving average is 1.40, which suggests DRMA is a Buy.
          What is DRMA’s 20-day moving average?
          DRMA 20-day moving average is 1.27, which suggests DRMA is a Buy.
            What is DRMA’s 50-day moving average?
            DRMA’s 50-day moving average is 1.66, which suggests DRMA is a Sell.
              What is DRMA’s 200-day moving average?
              DRMA’s 200-day moving average is 4.02, which suggests DRMA is a Sell.
                What is DRMA’s Williams % R (14)?
                DRMA’s Williams % R (14) is -42.65, which suggests DRMA is a Buy.
                  What is DRMA’s CCI (14)?
                  DRMA’s CCI (14) is 193.05, which suggests DRMA is a Sell.